PPARA and Parkinson disease: Although the mechanism(s) of action for PPARα-mediated neuroprotection in Parkinson's disease have not been fully defined, Barbiero et al. found that fenofibrate-treated animals had decreased levels of oxidative stress biomarkers, suggesting an antioxidant effect [8, 58].